Literature DB >> 2040306

Studies on the intracellular distributions of soluble epoxide hydrolase and of catalase by digitonin-permeabilization of hepatocytes isolated from control and clofibrate-treated mice.

A M Eriksson1, M A Zetterqvist, B Lundgren, K Andersson, B Beije, J W DePierre.   

Abstract

Digitonin permeabilization of hepatocytes from control and clofibrate-treated (0.5% by mass, 10 days) male C57bl/6 mice was used to study the intracellular distributions of soluble ('cytosolic') epoxide hydrolase and of catalase. The following conclusions were drawn. (1) About 60% of the total soluble epoxide hydrolase activity in control mouse hepatocytes is situated in the cytosol. (2) The rest is not mitochondrial, but probably peroxisomal. (3) Of the total catalase activity in control mouse hepatocytes, 5-10% is found in the cytosol. (4) Treatment of mice with clofibrate increases the total hepatocyte activity of soluble epoxide hydrolase 4-fold, but does not influence the relative distribution of this enzyme between cytosol and peroxisomes. (5) The total catalase activity is increased 3.5-fold by clofibrate treatment and 15-35% of this activity is shifted from the peroxisomes to the cytosol.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2040306     DOI: 10.1111/j.1432-1033.1991.tb16037.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase.

Authors:  M A Argiriadi; C Morisseau; B D Hammock; D W Christianson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

2.  Monoclonal antibodies reveal multiple forms of expression of human microsomal epoxide hydrolase.

Authors:  Hongying Duan; Akira Takagi; Hidekazu Kayano; Isamu Koyama; Christophe Morisseau; Bruce D Hammock; Toshitaka Akatsuka
Journal:  Toxicol Appl Pharmacol       Date:  2012-01-28       Impact factor: 4.219

3.  Epoxyeicosatrienoic acids and soluble epoxide hydrolase: potential therapeutic targets for inflammation and its induced carcinogenesis.

Authors:  Stephanie Norwood; Jie Liao; Bruce D Hammock; Guang-Yu Yang
Journal:  Am J Transl Res       Date:  2010-07-22       Impact factor: 4.060

Review 4.  Biochemistry of peroxisomes in health and disease.

Authors:  I Singh
Journal:  Mol Cell Biochem       Date:  1997-02       Impact factor: 3.396

5.  Mitochondrial P450-dependent arachidonic acid metabolism by TCDD-induced hepatic CYP1A5; conversion of EETs to DHETs by mitochondrial soluble epoxide hydrolase.

Authors:  Erin M Labitzke; Silvia Diani-Moore; Arleen B Rifkind
Journal:  Arch Biochem Biophys       Date:  2007-08-25       Impact factor: 4.013

Review 6.  Soluble epoxide hydrolase: gene structure, expression and deletion.

Authors:  Todd R Harris; Bruce D Hammock
Journal:  Gene       Date:  2013-05-20       Impact factor: 3.688

7.  The effects of perfluoro-octanoic acid on hepatic peroxisome proliferation and related parameters show no sex-related differences in mice.

Authors:  A K Sohlenius; K Andersson; J W DePierre
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

8.  Substrate modulation of aldolase B binding in hepatocytes.

Authors:  L Agius
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

Review 9.  Epoxy-Oxylipins and Soluble Epoxide Hydrolase Metabolic Pathway as Targets for NSAID-Induced Gastroenteropathy and Inflammation-Associated Carcinogenesis.

Authors:  Ryan D Jones; Jie Liao; Xin Tong; Dandan Xu; Leyu Sun; Haonan Li; Guang-Yu Yang
Journal:  Front Pharmacol       Date:  2019-06-25       Impact factor: 5.810

10.  Farnesyl diphosphate synthase, the target for nitrogen-containing bisphosphonate drugs, is a peroxisomal enzyme in the model system Dictyostelium discoideum.

Authors:  James M Nuttall; Ewald H Hettema; Donald J Watts
Journal:  Biochem J       Date:  2012-11-01       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.